Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in stage III and IV ovarian carcinoma: long-term results of a phase II study.

Papadimitriou, C A

Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in stage III and IV ovarian carcinoma: long-term results of a phase II study. [electronic resource] - Cancer Oct 2000 - 1547-54 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article

0008-543X

10.1002/1097-0142(20001001)89:7<1547::aid-cncr19>3.0.co;2-p doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Cisplatin--administration & dosage
Drug Administration Schedule
Epirubicin--administration & dosage
Female
Granulocyte Colony-Stimulating Factor--administration & dosage
Humans
Infusions, Intravenous
Middle Aged
Ovarian Neoplasms--drug therapy
Paclitaxel--administration & dosage
Treatment Outcome